Chardan Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Chardan capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Chardan Capital Today - Breaking & Trending Today

Arthur A. Levin Sells 40,000 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) Stock

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) Director Arthur A. Levin sold 40,000 shares of Avidity Biosciences stock in a transaction that occurred on Wednesday, June 12th. The shares were sold at an average price of $35.07, for a total transaction of $1,402,800.00. Following the completion of the transaction, the director now directly owns […] ....

Los Angeles , United States , Arthura Levin , Los Angeles Capital Management , Proshare Advisors , Cantor Fitzgerald , Avidity Biosciences Company Profile , Avidity Biosciences Inc , Alps Advisors Inc , Board Of Administration Florida Retirement System , Needham Company , Hennion Walsh Asset Management Inc , Securities Exchange Commission , Avidity Biosciences , Get Free Report , Director Arthur , Exchange Commission , Chardan Capital , Florida Retirement System , Angeles Capital Management , Walsh Asset Management , Share Advisors , Alps Advisors , Avidity Biosciences Daily ,

Arbutus Biopharma Co. (NASDAQ:ABUS) Shares Sold by FourWorld Capital Management LLC

FourWorld Capital Management LLC lessened its stake in Arbutus Biopharma Co. (NASDAQ:ABUS – Free Report) by 18.7% in the 4th quarter, Holdings Channel.com reports. The fund owned 1,090,851 shares of the biopharmaceutical company’s stock after selling 251,056 shares during the quarter. Arbutus Biopharma comprises approximately 1.8% of FourWorld Capital Management LLC’s investment portfolio, making the […] ....

United States , Arbutus Biopharma Co , Holdings Channel , Barclays Plc , Arbutus Biopharma Corporation , Sg Americas Securities , Fourworld Capital Management , Path Wealth Partners , China Universal Asset Management Co , Arbutus Biopharma , Free Report , World Capital Management , Universal Asset Management , Chardan Capital , Get Free Report , Biopharma Corporation , Visit Holdingschannel , Arbutus Biopharma Daily ,

Investment Analysts' Updated EPS Estimates for June 12th (BNOX, BRTX, CASY, CFG, CPLF, CWB, MAMA, NICE, NSSC, PDSB)

Investment Analysts’ updated eps estimates for Wednesday, June 12th: Bionomics (NASDAQ:BNOX) had its buy rating reaffirmed by analysts at HC Wainwright. They currently have a $8.00 price target on the stock. BioRestorative Therapies (NASDAQ:BRTX) had its buy rating reaffirmed by analysts at Roth Mkm. Roth Mkm currently has a $15.00 price target on the stock. […] ....

William Blair , Roth Mkm , News Ratings For Bionomics Limited Daily , Citizens Financial Group , Jefferies Financial Group Inc , Royal Bank , National Bankshares Inc , Canadian Western Bank , Citigroup Inc , Morgan Stanley , Investment Analyst , Restorative Therapies , General Stores , Jefferies Financial Group , Financial Group , National Bankshares , Western Bank , Lake Street Capital , Security Technologies , Med Express , Chardan Capital , Bionomics Limited Daily , Bionomics Limited ,

VinFast Auto (NASDAQ:VFS) Stock Price Down 5.5%

VinFast Auto Ltd. (NASDAQ:VFS – Get Free Report)’s share price was down 5.5% during mid-day trading on Tuesday . The company traded as low as $4.56 and last traded at $4.60. Approximately 2,300,416 shares changed hands during trading, a decline of 12% from the average daily volume of 2,609,694 shares. The stock had previously closed […] ....

United States , Republic Of , Cantor Fitzgerald , Sg Americas Securities , Spare Parts Aftermarket Services , Vinfast Auto Ltd , Daiwa Securities Group Inc , Wolverine Asset Management , Vinfast Auto Company Profile , Vinfast Auto , Get Free Report , Chardan Capital , Fast Auto , Asset Management , Capital Management , Securities Group , Spare Parts , Vinfast Auto Daily ,

Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sarah Boyce Sells 28,000 Shares

Avidity Biosciences, Inc. (NASDAQ:RNA – Get Free Report) CEO Sarah Boyce sold 28,000 shares of the business’s stock in a transaction that occurred on Tuesday, June 4th. The shares were sold at an average price of $27.42, for a total value of $767,760.00. Following the completion of the transaction, the chief executive officer now directly […] ....

United States , Sarah Boyce , Vanguard Group Inc , Securities Exchange Commission , Raymond James Financial Services Advisors Inc , Cantor Fitzgerald , Avidity Biosciences Company Profile , Avidity Biosciences Inc , Mirae Asset Global Investments Co , Needham Company , Avidity Biosciences , Get Free Report , Exchange Commission , Capital Partners , James Financial Services Advisors , Asset Global Investments , Chardan Capital , Avidity Biosciences Daily ,